{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T02:44:55Z","timestamp":1792118695793,"version":"4.4.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 111-2628-B-A49-014 -"],"award-info":[{"award-number":["NSTC 111-2628-B-A49-014 -"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 112-2628-B-A49-012 -"],"award-info":[{"award-number":["NSTC 112-2628-B-A49-012 -"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005866","name":"Far Eastern Memorial Hospital","doi-asserted-by":"publisher","award":["FEMH-NYMU 112DN26"],"award-info":[{"award-number":["FEMH-NYMU 112DN26"]}],"id":[{"id":"10.13039\/501100005866","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.biopha.2023.116077","type":"journal-article","created":{"date-parts":[[2023,12,27]],"date-time":"2023-12-27T20:17:14Z","timestamp":1703708234000},"page":"116077","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Ergosterol peroxide blocks HDV infection as a novel entry inhibitor by targeting human NTCP receptor"],"prefix":"10.1016","volume":"170","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3990-2920","authenticated-orcid":false,"given":"Wei-Chung","family":"Chiou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Syuan","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-6899-5620","authenticated-orcid":false,"given":"Tzu-Lan","family":"Hsia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jui-Chieh","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6426-9696","authenticated-orcid":false,"given":"Lie-Chwen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Fu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Shiuan","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8220-1815","authenticated-orcid":false,"given":"Cheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.biopha.2023.116077_bib1","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/infdis\/jiz633","article-title":"Estimating the global prevalence, disease progression, and clinical outcome of hepatitis delta virus infection","volume":"221","author":"Miao","year":"2020","journal-title":"J. Infect. Dis."},{"issue":"5","key":"10.1016\/j.biopha.2023.116077_bib2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/hep.1840030518","article-title":"The delta agent","volume":"3","author":"Rizzetto","year":"1983","journal-title":"Hepatology"},{"issue":"10","key":"10.1016\/j.biopha.2023.116077_bib3","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrgastro.2016.126","article-title":"Hepatitis delta virus: insights into a peculiar pathogen and novel treatment options","volume":"13","author":"Lempp","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.116077_bib4","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/liv.14356","article-title":"Future treatments for hepatitis delta virus infection","volume":"40","author":"Asselah","year":"2020","journal-title":"Liver Int"},{"issue":"7","key":"10.1016\/j.biopha.2023.116077_bib5","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1128\/jvi.62.7.2403-2410.1988","article-title":"Human hepatitis delta antigen is a nuclear phosphoprotein with RNA-binding activity","volume":"62","author":"Chang","year":"1988","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2023.116077_bib6","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1128\/jvi.62.2.594-599.1988","article-title":"A single antigenomic open reading frame of the hepatitis delta virus encodes the epitope(s) of both hepatitis delta antigen polypeptides p24 delta and p27 delta","volume":"62","author":"Weiner","year":"1988","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.biopha.2023.116077_bib7","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/jvi.58.3.945-950.1986","article-title":"Hepatitis delta virus: protein composition of delta antigen and its hepatitis B virus-derived envelope","volume":"58","author":"Bonino","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.biopha.2023.116077_bib8","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1146\/annurev.bi.64.070195.001355","article-title":"The molecular biology of hepatitis delta virus","volume":"64","author":"Lai","year":"1995","journal-title":"Annu. Rev. Biochem."},{"issue":"7916","key":"10.1016\/j.biopha.2023.116077_bib9","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s41586-022-04845-4","article-title":"Structure of the bile acid transporter and HBV receptor NTCP","volume":"606","author":"Asami","year":"2022","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.biopha.2023.116077_bib10","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1128\/JVI.03478-13","article-title":"Viral entry of hepatitis B and D viruses and bile salts transportation share common molecular determinants on sodium taurocholate cotransporting polypeptide","volume":"88","author":"Yan","year":"2014","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.biopha.2023.116077_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117152","article-title":"Primary biliary acids inhibit hepatitis D virus (HDV) entry into human hepatoma cells expressing the sodium-taurocholate cotransporting polypeptide (NTCP)","volume":"10","author":"Veloso Alves Pereira","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.biopha.2023.116077_bib12","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1021\/acs.jnatprod.9b01285","article-title":"Natural products as sources of new drugs over the nearly four decades from 01\/1981 to 09\/2019","volume":"83","author":"Newman","year":"2020","journal-title":"J. Nat. Prod."},{"issue":"2","key":"10.1016\/j.biopha.2023.116077_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.bjp.0706972","article-title":"Ergosterol peroxide from an edible mushroom suppresses inflammatory responses in RAW264.7 macrophages and growth of HT29 colon adenocarcinoma cells","volume":"150","author":"Kobori","year":"2007","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.116077_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-36411-2","article-title":"Ergosterol peroxide from marine fungus Phoma sp. induces ROS-dependent apoptosis and autophagy in human lung adenocarcinoma cells","volume":"8","author":"Wu","year":"2018","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.biopha.2023.116077_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1615\/IntJMedMushrooms.v19.i2.10","article-title":"Ergosterol peroxide: a mushroom-derived compound with promising biological activities-a review","volume":"19","author":"Merdivan","year":"2017","journal-title":"Int. J. Med. Mushrooms"},{"key":"10.1016\/j.biopha.2023.116077_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2021.105184","article-title":"Ergosterol peroxide inhibits HBV infection by inhibiting the binding of the pre-S1 domain of LHBsAg to NTCP","volume":"195","author":"Huang","year":"2021","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.116077_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jhep.2006.08.018","article-title":"Serum-derived hepatitis C virus infectivity in interferon regulatory factor-7-suppressed human primary hepatocytes","volume":"46","author":"Aly","year":"2007","journal-title":"J. Hepatol."},{"issue":"3","key":"10.1016\/j.biopha.2023.116077_bib18","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.bbrc.2013.12.052","article-title":"Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP","volume":"443","author":"Iwamoto","year":"2014","journal-title":"Biochem Biophys. Res. Commun."},{"issue":"50","key":"10.1016\/j.biopha.2023.116077_bib19","doi-asserted-by":"crossref","first-page":"26226","DOI":"10.1074\/jbc.M116.754853","article-title":"Cellular nuclear export factors TAP and aly are required for HDAg-L-mediated assembly of hepatitis delta virus","volume":"291","author":"Huang","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.biopha.2023.116077_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"issue":"Web Server issue","key":"10.1016\/j.biopha.2023.116077_bib21","doi-asserted-by":"crossref","first-page":"W486","DOI":"10.1093\/nar\/gkr320","article-title":"ChemMine tools: an online service for analyzing and clustering small molecules","volume":"39","author":"Backman","year":"2011","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.biopha.2023.116077_bib22","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1021\/ci025531g","article-title":"Performance of similarity measures in 2D fragment-based similarity searching: comparison of structural descriptors and similarity coefficients","volume":"42","author":"Chen","year":"2002","journal-title":"J. Chem. Inf. Comput. Sci."},{"issue":"D1","key":"10.1016\/j.biopha.2023.116077_bib23","doi-asserted-by":"crossref","first-page":"D1388","DOI":"10.1093\/nar\/gkaa971","article-title":"PubChem in 2021: new data content and improved web interfaces","volume":"49","author":"Kim","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.biopha.2023.116077_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open babel: an open chemical toolbox","volume":"3","author":"O'Boyle","year":"2011","journal-title":"J. Chemin.-."},{"issue":"8","key":"10.1016\/j.biopha.2023.116077_bib25","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41422-022-00680-4","article-title":"Structure of human NTCP reveals the basis of recognition and sodium-driven transport of bile salts into the liver","volume":"32","author":"Liu","year":"2022","journal-title":"Cell Res"},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.116077_bib26","article-title":"iGEMDOCK: a graphical environment of enhancing GEMDOCK using pharmacological interactions and post-screening analysis","volume":"12","author":"Hsu","year":"2011","journal-title":"BMC Bioinforma."},{"issue":"9","key":"10.1016\/j.biopha.2023.116077_bib27","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.162404","article-title":"Persistent hepatic IFN system activation in HBV-HDV infection determines viral replication dynamics and therapeutic response","volume":"8","author":"Chida","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2023.116077_bib28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.09.009","article-title":"(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes","volume":"111","author":"Huang","year":"2014","journal-title":"Antivir. Res"},{"issue":"9","key":"10.1016\/j.biopha.2023.116077_bib29","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41575-020-0332-6","article-title":"Progress towards elimination goals for viral hepatitis","volume":"17","author":"Cox","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2023.116077_bib30","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1136\/gutjnl-2020-323888","article-title":"Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease","volume":"70","author":"Urban","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.116077_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2020.104853","article-title":"Characterization of the antiviral effects of REP 2139 on the HBV lifecycle in vitro","volume":"183","author":"Boulon","year":"2020","journal-title":"Antivir. Res"},{"key":"10.1016\/j.biopha.2023.116077_bib32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.coviro.2018.04.004","article-title":"Virus entry and its inhibition to prevent and treat hepatitis B and hepatitis D virus infections","volume":"30","author":"Tu","year":"2018","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2023.116077_bib33","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/gutjnl-2017-314713","article-title":"Hepatitis delta virus persists during liver regeneration and is amplified through cell division both in vitro and in vivo","volume":"68","author":"Giersch","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2023.116077_bib34","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.00049","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Yan","year":"2012","journal-title":"Elife"},{"issue":"4","key":"10.1016\/j.biopha.2023.116077_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004840","article-title":"Hepatitis D VIrus Infection of Mice Expressing Human Sodium Taurocholate Co-transporting Polypeptide","volume":"11","author":"He","year":"2015","journal-title":"PLoS Pathog."},{"issue":"19","key":"10.1016\/j.biopha.2023.116077_bib36","doi-asserted-by":"crossref","first-page":"8866","DOI":"10.1128\/JVI.00901-16","article-title":"Modification of three amino acids in sodium taurocholate cotransporting polypeptide renders mice susceptible to infection with hepatitis D virus in vivo","volume":"90","author":"He","year":"2016","journal-title":"J. Virol."},{"issue":"447","key":"10.1016\/j.biopha.2023.116077_bib37","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap9328","article-title":"Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection","volume":"10","author":"Winer","year":"2018","journal-title":"Sci. Transl. Med"},{"issue":"4","key":"10.1016\/j.biopha.2023.116077_bib38","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jhep.2022.05.023","article-title":"Hepatitis D virus-induced interferon response and administered interferons control cell division-mediated virus spread","volume":"77","author":"Zhang","year":"2022","journal-title":"J. Hepatol."},{"issue":"9","key":"10.1016\/j.biopha.2023.116077_bib39","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1111\/j.1478-3231.2011.02593.x","article-title":"Hepatitis D virus-specific cytokine responses in patients with chronic hepatitis delta before and during interferon alfa-treatment","volume":"31","author":"Grabowski","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.biopha.2023.116077_bib40","doi-asserted-by":"crossref","first-page":"1189417","DOI":"10.3389\/fcimb.2023.1189417","article-title":"Metabolomics in viral hepatitis: advances and review","volume":"13","author":"Yang","year":"2023","journal-title":"Front Cell Infect. Microbiol"},{"issue":"1","key":"10.1016\/j.biopha.2023.116077_bib41","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"23","key":"10.1016\/j.biopha.2023.116077_bib42","doi-asserted-by":"crossref","first-page":"11945","DOI":"10.1128\/JVI.01855-15","article-title":"A novel tricyclic polyketide, vanitaracin A, specifically inhibits the entry of hepatitis B and D viruses by targeting sodium taurocholate cotransporting polypeptide","volume":"89","author":"Kaneko","year":"2015","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.biopha.2023.116077_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15338-0","article-title":"Reduced hepatitis B and D viral entry using clinically applied drugs as novel inhibitors of the bile acid transporter NTCP","volume":"7","author":"Donkers","year":"2017","journal-title":"Sci. Rep."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223018759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223018759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T00:44:56Z","timestamp":1773967496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223018759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":43,"alternative-id":["S0753332223018759"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116077","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ergosterol peroxide blocks HDV infection as a novel entry inhibitor by targeting human NTCP receptor","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.116077","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116077"}}